FRUTTAROLO, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 2.930
EU - Europa 1.640
AS - Asia 622
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 5.199
Nazione #
US - Stati Uniti d'America 2.930
DE - Germania 782
CN - Cina 367
UA - Ucraina 273
TR - Turchia 191
RU - Federazione Russa 177
GB - Regno Unito 149
SE - Svezia 104
IT - Italia 64
FI - Finlandia 56
SG - Singapore 50
FR - Francia 13
BE - Belgio 6
CZ - Repubblica Ceca 4
IR - Iran 4
EU - Europa 3
LT - Lituania 3
NL - Olanda 3
HK - Hong Kong 2
IL - Israele 2
IN - India 2
PS - Palestinian Territory 2
AU - Australia 1
BR - Brasile 1
CL - Cile 1
EG - Egitto 1
GR - Grecia 1
IE - Irlanda 1
KR - Corea 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.199
Città #
Woodbridge 434
Fairfield 321
Jacksonville 280
Ann Arbor 271
Houston 223
Chandler 206
Ashburn 166
Wilmington 156
Seattle 125
Beijing 93
Cambridge 84
Izmir 81
Nanjing 80
Boardman 64
Princeton 61
Bremen 55
San Diego 38
Shanghai 34
Singapore 28
Nanchang 25
San Mateo 22
Shenyang 22
Changsha 20
Milan 18
Falls Church 16
Jiaxing 14
Philadelphia 14
Hebei 12
Kunming 12
New York 12
Tianjin 12
Auburn Hills 9
London 9
Orange 9
Zhengzhou 9
Indiana 8
Jinan 8
Mountain View 8
Brussels 6
Dearborn 5
Guangzhou 5
Helsinki 5
Redwood City 5
Tappahannock 5
Bari 4
Kilburn 4
Los Angeles 4
Ningbo 4
Norwalk 4
Ferrara 3
Florence 3
Haikou 3
Lanzhou 3
Redmond 3
Taizhou 3
Verona 3
Washington 3
Brno 2
Chiswick 2
Hangzhou 2
Hong Kong 2
Tel Aviv 2
Tulkarm 2
Walnut 2
Wandsworth 2
Yellow Springs 2
Acton 1
Bangor 1
Belgrade 1
Bologna 1
Bratislava 1
Caen 1
Chongqing 1
Dehradun 1
Den Haag 1
Dublin 1
Düsseldorf 1
Fuzhou 1
Hefei 1
Kingston Upon Thames 1
Logan 1
New Bedfont 1
North Bergen 1
Olomouc 1
Patrocinio 1
Pietro 1
Prescot 1
Qingdao 1
Saint Petersburg 1
Tabriz 1
Thessaloníki 1
Vilnius 1
Winter Park 1
Totale 3.179
Nome #
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 152
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 149
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 138
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 136
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 133
DNA minor groove binders as potential antitumor and antimicrobial agents 131
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 130
Hybrid molecules based on distamycin A as potential antitumor agents 128
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 127
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 124
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 123
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 122
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agents 122
Recent improvements in the development of A2B adenosine receptor agonists. 121
null 120
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 117
Allosteric enhancers for A(1) adenosine receptor 112
Hybrid molecules between distamycin A and active moieties of antitumor agents 111
null 110
Recent improvements in the development of A2B adenosine receptor agonists 110
Synthesis of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines and related heterocycles 105
null 104
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 100
Recent developments in the field of adenosine receptor ligands. 100
New 2-arylpyrazolo[4,3-c]quinoline derivates as potent and selective human A3 adenosine receptor antagonists 99
Structure-activity relationships around the KN-62, a potent antagonist of the P2X(7)receptor 98
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and linked heterocycles as template for the adenosine receptor antagonism: medicinal chemistry approach and SAR considerations. 97
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A(3) adenosine receptors in human tumor cell lines 95
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 95
Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models 94
Synthesis and biological evaluation of novel N-6-[4-(substituted) sulfonamidophenylcarbamoyl]adenosine-5 '-uronamides as A(3) adenosine receptor agonists 92
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 91
New strategies for the synthesis of A(3) adenosine receptor antagonists 89
Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cells 88
Recent developments in the field of A(2A) and A(3) adenosine receptor antagonists 88
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 87
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 85
null 82
Recent developments in the field of A2B and A3 adenosine receptors antagonists 80
Recent developments in the field of adenosine receptor ligands 80
New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A(3) adenosine receptor antagonists 79
Recent improvements in the field of A(3) adenosine receptor ligands 75
Ligands for A(2B) adenosine receptor subtype 74
New pyrrolo [2,1-f] purine-2,4-dione and Imidazo[2,1-f]purine-2,4-dione derivates as potent and selective human A3 adenosine receptor antagonists 74
Preparation of O-substituted-dibenzyl (thio)urea derivatives as TRPV1 receptor antagonists. 73
null 73
O-SUBSTITUTED-DIBENZYL UREA-DERIVATIVES AS TRPV1 RECEPTOR ANTAGONISTS 71
Preparation of isoquinolinyl cyclohexenylacrylamides as transient receptor potential vanilloid 1 (TRPV1) receptor antagonists 65
Synthesis and biological evaluation of new 8-heterocyclic xanthine derivative as highly potent and selective human A2B adenosine receptor antagonist 65
Preparation of N-aryl biarylcarboxamides as vanilloid-1 receptor modulators. 60
Preparation of O-substituted-dibenzyl urea derivatives as TRPV1 receptor antagonists. 58
Synthesis and biological evaluation of 2-amino-3-(3 ',4 ',5 '-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents 21
Recent developments in the field of A(3) adenosine receptor antagonists 21
DNA minor-groove binders. Design, synthesis, and biological evaluation of ligands structurally related to CC-1065, distamycin, and anthramycin 19
Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]-9H-purin-9-yl]-N-ethyl-be ta-D-ribofuranuronamide derivatives as useful templates for the development of A(2B) adenosine receptor agonists 15
Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: A possible template for adenosine receptor subtypes? 11
Totale 5.219
Categoria #
all - tutte 17.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020916 161 27 27 126 49 103 62 85 60 122 80 14
2020/2021596 103 69 15 69 19 68 14 67 11 62 72 27
2021/2022575 12 69 42 26 41 26 21 21 16 36 55 210
2022/2023545 53 6 10 70 144 86 6 43 82 3 26 16
2023/2024255 29 33 13 4 12 18 25 28 6 2 5 80
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 5.219